These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Self-measurement of blood pressure at home to evaluate drug effects by the trough: peak ratio. Ménard J; Chatellier G; Day M; Vaur L J Hypertens Suppl; 1994 Nov; 12(8):S21-5. PubMed ID: 7707151 [TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of drugs: statistical distribution of the trough-to-peak ratio. Chi VX; Chau NP Biometrics; 1996 Mar; 52(1):286-90. PubMed ID: 8934597 [TBL] [Abstract][Full Text] [Related]
4. [The trough/peak ratio]. Salvetti A; Virdis A Ann Ital Med Int; 1995 Oct; 10 Suppl():91S-95S. PubMed ID: 8562276 [TBL] [Abstract][Full Text] [Related]
5. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio]. Hitzenberger G Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727 [TBL] [Abstract][Full Text] [Related]
7. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring? Neutel JM; Smith DH; Weber MA Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419 [TBL] [Abstract][Full Text] [Related]
8. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations. Lipicky RJ J Hypertens Suppl; 1994 Nov; 12(8):S17-8; discussion S18-9. PubMed ID: 7707150 [TBL] [Abstract][Full Text] [Related]
9. [Valley/peak ratio and pressure changes during treatment with fosinopril in hypertensive elderly patients]. Cicconetti P; Salza MC; Rizzo V; Bianchi A; Capponi L; Marigliano V Clin Ter; 1996; 147(7-8):359-64. PubMed ID: 9118617 [TBL] [Abstract][Full Text] [Related]
10. Use of trough:peak ratio in the assessment of antihypertensive drug therapy. Myers MG Can J Cardiol; 1994 Nov; 10 Suppl D():17D-20D. PubMed ID: 7954034 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the effectiveness of antihypertensive therapy. Is the trough-peak ratio the determining factor?]. Widimský J Vnitr Lek; 1996 Feb; 42(2):102-5. PubMed ID: 8686181 [TBL] [Abstract][Full Text] [Related]
12. New FDA guidelines on the treatment of hypertension: comparison of different therapeutic classes according to trough/peak blood pressure responses. Meredith PA Arch Mal Coeur Vaiss; 1994 Nov; 87(11):1423-9. PubMed ID: 7771888 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive treatment: full 24 hour control and trough to peak ratio. Meredith PA Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):339-43. PubMed ID: 12497931 [No Abstract] [Full Text] [Related]
14. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect]. Parati G; Omboni S; Mancia G Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):345-8. PubMed ID: 12497932 [No Abstract] [Full Text] [Related]
15. [Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications]. Polónia J Rev Port Cardiol; 1996 Apr; 15(4):281-92. PubMed ID: 8814671 [No Abstract] [Full Text] [Related]
16. [The trough-to-peak ratio in the evaluation of an antihypertensive drug]. Mancia G; Salvetti A G Ital Cardiol; 1994 Aug; 24(8):1043-8. PubMed ID: 7958635 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the trough-to-peak ratio of cardio-selective beta-blockers in patients with newly diagnosed hypertension. Soucek M; Rihacek I; Frana P Blood Press Monit; 2006 Dec; 11(6):337-42. PubMed ID: 17106318 [TBL] [Abstract][Full Text] [Related]
18. [How relevant is the trough-to peak ratio?]. Ferrari P Schweiz Med Wochenschr; 2000 Mar; 130(9):329-35. PubMed ID: 10746273 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles. Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191 [TBL] [Abstract][Full Text] [Related]
20. Trough-to-peak ratio and 24-hour blood pressure control. Methodologic issues. Myers MG Am J Hypertens; 1995 Feb; 8(2):214-9. PubMed ID: 7755954 [No Abstract] [Full Text] [Related] [Next] [New Search]